Living alone, obesity and smoking: Important factors for quality of life after radiotherapy and androgen deprivation therapy for prostate cancer

References

• Ferlay J, Parkin DM, Steliarova-Foucher E. Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer 2010;46:765–81.
   PubMed Web of Science ®Google Scholar
• Cancerregisteret 2009. Copenhagen: Sundhedsstyrelsen; 2010. Available from: http://www.sst.dk [cited 2011 Oct 25].
   Google Scholar
• Harmenberg U, Hamdy FC, Widmark A, Lennernas B, Nilsson S. Curative radiation therapy in prostate cancer. Acta Oncol 2011;50(Suppl 1):98–103.
   PubMed Web of Science ®Google Scholar
• Widmark A, Klepp O, Solberg A, Damber JE, Angelsen A, Fransson P, . Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): An open randomised phase III trial. Lancet 2009;373:301–8.
   PubMed Web of Science ®Google Scholar
• Potosky AL, Davis WW, Hoffman RM, Stanford JL, Stephenson RA, Penson DF, . Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: The prostate cancer outcomes study. J Natl Cancer Inst 2004;96:1358–67.
   PubMed Web of Science ®Google Scholar
• Michaelson MD, Cotter SE, Gargollo PC, Zietman AL, Dahl DM, Smith MR. Management of complications of prostate cancer treatment. CA Cancer J Clin 2008;58:196–213.
   PubMed Web of Science ®Google Scholar
• Alibhai SM, Breunis H, Timilshina N, Johnston C, Tomlinson G, Tannock I, . Impact of androgen-deprivation therapy on physical function and quality of life in men with nonmetastatic prostate cancer. J Clin Oncol 2010;28:5038–45.
   PubMed Web of Science ®Google Scholar
• Dalton SO, Laursen TM, Ross L, Mortensen PB, Johansen C. Risk for hospitalization with depression after a cancer diagnosis: A nationwide, population-based study of cancer patients in Denmark from 1973 to 2003. J Clin Oncol 2009;27: 1440–5.
   PubMed Web of Science ®Google Scholar
• Pardo Y, Guedea F, Aguilo F, Fernandez P, Macias V, Marino A, . Quality-of-life impact of primary treatments for localized prostate cancer in patients without hormonal treatment. J Clin Oncol 2010;28:4687–96.
   PubMed Web of Science ®Google Scholar
• Sanda MG, Dunn RL, Michalski J, Sandler HM, Northouse L, Hembroff L, . Quality of life and satisfaction with outcome among prostate-cancer survivors. New Engl J Med 2008;358:1250–61.
   PubMed Web of Science ®Google Scholar
• Ware J, Jr., Kosinski M, Keller SD. A 12-Item Short-Form Health Survey: Construction of scales and preliminary tests of reliability and validity. Med Care 1996;34:220–33.
   PubMed Web of Science ®Google Scholar
• Wei J, Dunn R, Litwin M, Sandler H, Sanda M. Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer. Urology 2000;56:899–905.
   PubMed Web of Science ®Google Scholar
• Szymanski KM, Wei JT, Dunn RL, Sanda MG. Development and validation of an abbreviated version of the expanded prostate cancer index composite instrument for measuring health-related quality of life among prostate cancer survivors. Urology 2010;76:1245–50.
   PubMed Web of Science ®Google Scholar
• Norman GR, Sloan JA, Wyrwich KW. Interpretation of changes in health-related quality of life: The remarkable universality of half a standard deviation. Med Care 2003;41:582–92.
   PubMed Web of Science ®Google Scholar
• Wei JT, Dunn RL, Sandler HM, McLaughlin PW, Montie JE, Litwin MS, . Comprehensive comparison of health-related quality of life after contemporary therapies for localized prostate cancer. J Clin Oncol 2002;20:557–66.
   PubMed Web of Science ®Google Scholar
• Christensen AI, Davidsen M, Ekholm O, Hansen SE, Holst M, Juel K. Den nationale sundhedsprofil 2010 – hvordan har du det? Copenhagen: Sundhedsstyrelsen; 2011.
   Google Scholar
• Wedlake LJ, Thomas K, Lalji A, Blake P, Khoo VS, Tait D, . Predicting late effects of pelvic radiotherapy: Is there a better approach? Int J Radiat Oncol Biol Phys 2010;78:1163–70.
   PubMed Web of Science ®Google Scholar
• Alsadius D, Hedelin M, Johansson KA, Pettersson N, Wilderang U, Lundstedt D, . Tobacco smoking and long-lasting symptoms from the bowel and the anal-sphincter region after radiotherapy for prostate cancer. Radiother Oncol 2011;101:495–501.
   PubMed Web of Science ®Google Scholar
• Haseen F, Murray LJ, Cardwell CR, O’Sullivan JM, Cantwell MM. The effect of androgen deprivation therapy on body composition in men with prostate cancer: Systematic review and meta-analysis. J Cancer Surviv 2010;4;128–39.
   PubMed Web of Science ®Google Scholar
• Danmarks Statistik [Internet]. [cited 2011 Oct 25]. Copenhagen: Statistics Denmark; 2011. Available from: http://www.dst.dk.
   Google Scholar
• Wallace M, Storms S. The needs of men with prostate cancer: Result of a focus group study. Appl Nurs Res 2007;20:181–7.
   PubMed Web of Science ®Google Scholar
• Kazer MW, Harden J, Burke M, Sanda MG, Hardy J, Bailey DE. The experiences of unpartnered men with prostate cancer: A qualitative analysis. J Cancer Surviv 2011;5: 132–41.
   PubMed Web of Science ®Google Scholar
• Johansen C. Rehabilitation of cancer patients – research perspectives. Acta Oncol 2007;46:441–5.
   PubMed Web of Science ®Google Scholar
• Galvao DA, Taaffe DR, Spry N, Joseph D, Newton RU. Combined resistance and aerobic exercise program reverses muscle loss in men undergoing androgen suppression therapy for prostate cancer without bone metastases: A randomized controlled trial. J Clin Oncol 2010;28:340–7.
   PubMed Web of Science ®Google Scholar
• Rottmann N, Dalton SO, Bidstrup PE, Würtzen H, Høybye MT, Ross L, . No improvement in distress and quality of life following psychosocial cancer rehabilitation. A randomised trial. Psychooncology 2012;21:505–14.
   PubMed Web of Science ®Google Scholar